EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSOMEG00000012628
Gene Symbol: TAAR1
1 Cross references
376 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSOMEG00000012608
Gene Symbol: LOC112158158
2 Cross references
361 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSOMEG00000010171
Gene Symbol: TRPA1B
1 Cross references
200 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSOMEG00000021592
Gene Symbol: LOC112161307
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSOMEG00000017182
Gene Symbol: TPH1A
1 Cross references
207 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSOMEG00000001456
Gene Symbol: TUBA4A
4 Cross references
156 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSOMEG00000020878
Gene Symbol: TUBA4A
1 Cross references
170 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSOMEG00000014654
Gene Symbol: LOC112143676
3 Cross references
160 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSOMEG00000004353
Gene Symbol: LOC112147666
3 Cross references
305 Possible Orthologues:

Tubulin Beta-4b Chain-Like

Ensembl ID : ENSOMEG00000000260
Gene Symbol: LOC112146473
2 Cross references
17 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSOMEG00000014320
Gene Symbol: LOC112153026
3 Cross references
185 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOMEG00000014949
Gene Symbol: TYR
4 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).